ArticleJournal of Cancer2024

Synergistic Anti-Tumor Efficacy Achieved by Reversing Drug Resistance through the Regulation of the Tumor Immune Microenvironment with IL-12 and Osimertinib Combination Therapy.

Huiqin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.